Showing results (171-180 of 225) with videos related to

Sort By:
Pageof 23
Zeitschrift Fur Rheumatologie|April 24, 2008
[A view Down Under. Self-management initiatives and patient education in Australia]M Schwarze, R Kirchhof, M Schuler, et al.
Journal of Medicinal Chemistry|May 1, 1984
Synthesis and central nervous system properties of 2-[(alkoxycarbonyl)amino]-4(5)-phenyl-2-imidazolinesK Weinhardt, C C Beard, C Dvorak, et al.
British Journal of Haematology|February 13, 2001
Interleukin 12 induces activation of fibrinolysis and coagulation in humansJ E Portielje, W H Kruit, A J Eerenberg, et al.
Schmerz (Berlin, Germany)|July 20, 2012
[Pain assessment in elderly nursing home residents: methods paper for the S3-guideline development]E Sirsch, M Schuler, T Fischer, et al.
Cancer Immunology, Immunotherapy : CII|February 3, 2009
HLA ligand profiles of primary renal cell carcinoma maintained in metastasesJuliane Sarah Stickel, Andreas O Weinzierl, Nina Hillen, et al.
Health and Quality of Life Outcomes|June 27, 2018
Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status toolsH J Alma, C de Jong, D Jelusic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trialM Guberina, W Eberhardt, M Stuschke, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Virtual reality support during systemic cancer therapy to improve anxiety/depressive symptoms and reduce toxicity in patients with gastrointestinal cancers-OncoVRS Kasper, S Liszio, K Schorrmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancerJ E Portielje, W H Kruit, M Schuler, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases-the PURPLE trialS Kasper, E Elez, U Neumann, et al.
Pageof 23